Literature DB >> 2383472

Antibody transport and internalization into tumours.

S Matzku1, G Moldenhauer, H Kalthoff, S Canevari, M Colnaghi, J Schuhmacher, H Bihl.   

Abstract

Internalization of monoclonal antibody (MAb) conjugates is an important feature of tumour targeting, both with respect to the therapeutic action of substances coupled to the antibody and to retention of radionuclides. Problems of analysing internalization in vitro and in vivo, of manipulating internalization, and of evaluating the involvement of normal tissues are illustrated by recent experimental data and are discussed in the light of published evidence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383472      PMCID: PMC2149524     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  30 in total

1.  HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.

Authors:  B Dörken; G Moldenhauer; A Pezzutto; R Schwartz; A Feller; S Kiesel; L M Nadler
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

2.  Endocytosis of a monoclonal antibody recognising a cell surface glycoprotein antigen visualised using fluorescent conjugates.

Authors:  M C Garnett; R W Baldwin
Journal:  Eur J Cell Biol       Date:  1986-08       Impact factor: 4.492

3.  Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies.

Authors:  J F Lesley; R J Schulte
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

4.  Enhanced binding activity observed between anti-carcinoembryonic monoclonal antibodies.

Authors:  R Wellerson; P Kaplan
Journal:  Hybridoma       Date:  1986

5.  Modes of binding and internalization of monoclonal antibodies to human melanoma cell lines.

Authors:  S Matzku; E B Bröcker; J Brüggen; W G Dippold; W Tilgen
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

6.  A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo.

Authors:  R C Pittman; T E Carew; C K Glass; S R Green; C A Taylor; A D Attie
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

7.  Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma.

Authors:  J A Carrasquillo; J L Mulshine; P A Bunn; J C Reynolds; K A Foon; R W Schroff; P Perentesis; R G Steis; A M Keenan; M Horowitz
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

8.  Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies.

Authors:  C C Badger; K A Krohn; H Shulman; N Flournoy; I D Bernstein
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

9.  Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy.

Authors:  C M Haskell; F Buchegger; M Schreyer; S Carrel; J P Mach
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

10.  Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

Authors:  S Miotti; S Canevari; S Ménard; D Mezzanzanica; G Porro; S M Pupa; M Regazzoni; E Tagliabue; M I Colnaghi
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

View more
  1 in total

1.  A novel assay for monitoring internalization of nanocarrier coupled antibodies.

Authors:  Ulrik B Nielsen; Dmitri B Kirpotin; Edward M Pickering; Daryl C Drummond; James D Marks
Journal:  BMC Immunol       Date:  2006-10-02       Impact factor: 3.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.